Telmisartan and Amlodipine
- Product NDC
- 62332-185
- Requested package NDC
- 62332-185-10
- 11-digit product format
- 623320185
- Labeler code
- 62332
- Product ID
- 62332-185_3c17512c-6361-49b7-8531-a45ab1342de7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Telmisartan and Amlodipine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA205234
- Marketing category
- ANDA
- Marketing start
- 2026-03-31
- Substance
- TELMISARTAN; AMLODIPINE BESYLATE
- Active strength
- 40; 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205234-001 | TELMISARTAN AND AMLODIPINE | AMLODIPINE BESYLATE; TELMISARTAN | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | ||
| A205234-002 | TELMISARTAN AND AMLODIPINE | AMLODIPINE BESYLATE; TELMISARTAN | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | ||
| A205234-003 | TELMISARTAN AND AMLODIPINE | AMLODIPINE BESYLATE; TELMISARTAN | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | ||
| A205234-004 | TELMISARTAN AND AMLODIPINE | AMLODIPINE BESYLATE; TELMISARTAN | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205234-001 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205234-002 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;40MG | TABLET / ORAL | 2016-11-17 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205234-003 | TELMISARTAN AND AMLODIPINE | EQ 5MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205234-004 | TELMISARTAN AND AMLODIPINE | EQ 10MG BASE;80MG | TABLET / ORAL | 2016-11-17 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A205234-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A205234-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A205234-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A205234-004 | AB | 1 | 74a2ff9319b5… |
| 2020-11-12 02:37 UTC | 2020-11 | A205234-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A205234-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A205234-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A205234-004 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A205234-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A205234-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A205234-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A205234-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A205234-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A205234-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A205234-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A205234-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A205234-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A205234-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A205234-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A205234-004 | AB | 1 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Telmisartan and Amlodipine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TELMISARTAN | 40 mg/1 |
| AMLODIPINE BESYLATE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U5SYW473RQ | Internal UNII lookup |
| 864V2Q084H | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 14f9b590-4c43-439c-a647-9fc2b0fd4d7f | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 205234 ANDA205234 |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Inc. | 14f9b590-4c43-439c-a647-9fc2b0fd4d7f | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 205234 ANDA205234 62332-185-10 62332-185 62332018510 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 62332-185-10 | 62332018510 | 30 BLISTER PACK in 1 CARTON (62332-185-10) / 10 TABLET in 1 BLISTER PACK (62332-185-03) | 30 blister pack | 2026-03-31 | No | No | Current |